title: PHARMAC responds on long-acting insulin analogues.
authors.forename: Scott
authors.initials: S
authors.lastname: Metcalfe
authors.forename: Jackie
authors.initials: J
authors.lastname: Evans
authors.forename: Peter
authors.initials: P
authors.lastname: Moodie
mesh_terms: D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000188:drug therapy*; D017277:Drug Approval / Q000191:economics*; D015276:Health Care Rationing / Q000191:economics; D006801:Humans; D049528:Insulin, Long-Acting / Q000031:analogs & derivatives*; D009313:National Health Programs / Q000191:economics; D009520:New Zealand
chemical_list: D049528:Insulin, Long-Acting